Select Content Type
Clinical Guidelines
Interests
Cardiology
Internal/Family Medicine
Speciality
Cardiology
Internal/Family Medicine
Book Detail
volume
38 Suppl
ISSN
1935-5548
Publication Date
Actions
Download in App
Event Data
{"article_title":"(8) Cardiovascular disease and risk management.","author":"","journal_title":"Diabetes care","issn":"1935-5548","isbn":"","publication_date":"2023 Feb 19","volume":"38 Suppl","issue":"","first_page":"S49","page_count":"","accession_number":"25537708","doi":"10.2337\/dc15-S011","publisher":"American Diabetes Association","doctype":"Journal Article","subjects":"Antihypertensive Agents therapeutic use; Cardiovascular Diseases prevention & control; Diabetes Complications therapy; Diabetes Mellitus therapy; Hypolipidemic Agents therapeutic use; Platelet Aggregation Inhibitors therapeutic use; Risk Reduction Behavior; Cardiovascular Diseases complications; Cardiovascular Diseases therapy; Coronary Disease complications; Coronary Disease diagnosis; Coronary Disease therapy; Diabetes Complications complications; Disease Management; Dyslipidemias complications; Dyslipidemias therapy; Fibric Acids therapeutic use; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use; Hypertension complications; Hypertension therapy; Niacin therapeutic use","interest_area":["Cardiology"," Internal Medicine"],"abstract":"","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=25537708&authtype=shib&custid=ns346513&group=main&profile=eds","isPdfLink":true,"isSAML":false,"additionalInfo":{"Corporate_Authors":"American Diabetes Association","Journal_Info":"Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline","Published_Date":"2015-01-01","Source":"Diabetes care [Diabetes Care] 2015 Jan; Vol. 38 Suppl, pp. S49-57.","Languages":"English","Electronic_ISSN":"1935-5548","MeSH_Terms":"Risk Reduction Behavior*, Antihypertensive Agents\/*therapeutic use , Cardiovascular Diseases\/*prevention & control , Diabetes Complications\/*therapy , Diabetes Mellitus\/*therapy , Hypolipidemic Agents\/*therapeutic use , Platelet Aggregation Inhibitors\/*therapeutic use, Cardiovascular Diseases\/complications ; Cardiovascular Diseases\/therapy ; Coronary Disease\/complications ; Coronary Disease\/diagnosis ; Coronary Disease\/therapy ; Diabetes Complications\/complications ; Disease Management ; Dyslipidemias\/complications ; Dyslipidemias\/therapy ; Fibric Acids\/therapeutic use ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors\/therapeutic use ; Hypertension\/complications ; Hypertension\/therapy ; Niacin\/therapeutic use","Subjects":"Cardiovascular Diseases complications, Cardiovascular Diseases therapy, Coronary Disease complications, Coronary Disease diagnosis, Coronary Disease therapy, Diabetes Complications complications, Disease Management, Dyslipidemias complications, Dyslipidemias therapy, Fibric Acids therapeutic use, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Hypertension complications, Hypertension therapy, Niacin therapeutic use, Antihypertensive Agents therapeutic use, Cardiovascular Diseases prevention & control, Diabetes Complications therapy, Diabetes Mellitus therapy, Hypolipidemic Agents therapeutic use, Platelet Aggregation Inhibitors therapeutic use, Risk Reduction Behavior","Title_Abbreviations":"Diabetes care","Volume":"38 Suppl"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"25537708","RelevancyScore":"778","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"778.456298828125"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=25537708&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=25537708&authtype=shib&custid=ns346513&group=main&profile=eds"}
ISSN
1935-5548
IS_Ebsco
true
Upload Link
https://search.ebscohost.com/login.aspx?direct=true&db=mdl&AN=25537708&authtype=shib&custid=ns346513&group=main&profile=eds
Additional Info
["American Diabetes Association","Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE","Journal Article; Practice Guideline","2015-01-01","Diabetes care [Diabetes Care] 2015 Jan; Vol. 38 Suppl, pp. S49-57.","English","1935-5548","Risk Reduction Behavior*, Antihypertensive Agents\/*therapeutic use , Cardiovascular Diseases\/*prevention & control , Diabetes Complications\/*therapy , Diabetes Mellitus\/*therapy , Hypolipidemic Agents\/*therapeutic use , Platelet Aggregation Inhibitors\/*therapeutic use, Cardiovascular Diseases\/complications ; Cardiovascular Diseases\/therapy ; Coronary Disease\/complications ; Coronary Disease\/diagnosis ; Coronary Disease\/therapy ; Diabetes Complications\/complications ; Disease Management ; Dyslipidemias\/complications ; Dyslipidemias\/therapy ; Fibric Acids\/therapeutic use ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors\/therapeutic use ; Hypertension\/complications ; Hypertension\/therapy ; Niacin\/therapeutic use","Cardiovascular Diseases complications, Cardiovascular Diseases therapy, Coronary Disease complications, Coronary Disease diagnosis, Coronary Disease therapy, Diabetes Complications complications, Disease Management, Dyslipidemias complications, Dyslipidemias therapy, Fibric Acids therapeutic use, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Hypertension complications, Hypertension therapy, Niacin therapeutic use, Antihypertensive Agents therapeutic use, Cardiovascular Diseases prevention & control, Diabetes Complications therapy, Diabetes Mellitus therapy, Hypolipidemic Agents therapeutic use, Platelet Aggregation Inhibitors therapeutic use, Risk Reduction Behavior","Diabetes care","38 Suppl"]